The treatment of hyperlipidemia in patients infected with HIV is discussed. Hyperlipidemia is common in HIV-infected patients receiving antiretroviral therapy, especially protease inhibitors and ...
Hyperlipidemia Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The ...
Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...
DelveInsight’s Hyperlipidemia Market Insights report includes a comprehensive understanding of current treatment practices, hyperlipidemia emerging drugs, market share of individual therapies, and ...
PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 2b double blind, randomized MUIR study of investigational plozasiran (formerly ...
New drugs that dramatically lower cholesterol and treat hyperlipidemia are preparing to enter the market one after another. According to The New York Times, NYT, and The Wall Street Journal, WSJ, on ...
Objectives: To assess the influence of a low-fat, low-energy diet on the intake of vitamins and minerals in patients with overweight and hyperlipidemia. Setting: Outpatient clinic for hyperlipidemia ...
There have been theories as to why lipid abnormalities occur in the HIV-infected population, including those implicating both the infection and the antiretrovirals, but all have yet to be verified. [2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback